160 related articles for article (PubMed ID: 8575280)
1. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K; Bacus JW
Diagn Cytopathol; 1995 Oct; 13(3):214-23; discussion 224. PubMed ID: 8575280
[TBL] [Abstract][Full Text] [Related]
2. Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma. A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes.
Cajulis RS; Haines GK; Frias-Hidvegi D; McVary K
Anal Quant Cytol Histol; 1994 Feb; 16(1):1-10. PubMed ID: 8011035
[TBL] [Abstract][Full Text] [Related]
3. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
4. DNA flow cytometry and bladder irrigation cytology in detection of bladder carcinoma.
Kumar NU; Dey P; Mondal AK; Singh SK; Vohra H
Diagn Cytopathol; 2001 Mar; 24(3):153-6. PubMed ID: 11241896
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice.
Laudadio J; Keane TE; Reeves HM; Savage SJ; Hoda RS; Lage JM; Wolff DJ
BJU Int; 2005 Dec; 96(9):1280-5. PubMed ID: 16287445
[TBL] [Abstract][Full Text] [Related]
6. Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
Eleuteri P; Grollino MG; Pomponi D; Guaglianone S; Gallucci M; De Vita R
Eur Urol; 2000 Mar; 37(3):275-80. PubMed ID: 10720852
[TBL] [Abstract][Full Text] [Related]
7. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy.
Katz RL; Sinkre PA; Zhang HH; Kidd L; Johnston D
Cancer; 1997 Dec; 81(6):354-64. PubMed ID: 9438461
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry of transitional cell carcinoma of the urinary bladder: influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; Von Eschenbach AC; Barlogie B
Semin Diagn Pathol; 1987 Aug; 4(3):243-50. PubMed ID: 3671911
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
13. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides.
Skacel M; Pettay JD; Tsiftsakis EK; Procop GW; Biscotti CV; Tubbs RR
Anal Quant Cytol Histol; 2001 Dec; 23(6):381-7. PubMed ID: 11777271
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
15. Interphase cytogenetic diagnosis of bladder cancer on cells from urine and bladder washing.
Junker K; Werner W; Mueller C; Ebert W; Schubert J; Claussen U
Int J Oncol; 1999 Feb; 14(2):309-13. PubMed ID: 9917507
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
[No Abstract] [Full Text] [Related]
17. Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma?
Chen AA; Grasso M
J Endourol; 2008 Jun; 22(6):1371-4. PubMed ID: 18578665
[TBL] [Abstract][Full Text] [Related]
18. Bladder wash cytology and flow cytometry for the diagnosis of transitional cell carcinoma of the urinary bladder.
Romero J; Alos L; Mallofre C; Sole M; Gutierrez R; Alcover J; Carretero P
Eur Urol; 1992; 21 Suppl 1():13-5. PubMed ID: 1425832
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
20. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]